Mental Health Care as Core Alzheimer’s Treatment
2026-08-13
Depression in Alzheimer’s is not a side issue; it is a treatment target. Low mood, apathy, and anxiety correlate with faster loss of memory and executive function, according to multiple neuropsychiatric cohort studies that track both symptoms and Mini-Mental State Examination scores.
The sharper claim from clinicians is simple: treat the mood, and you often slow the slide. Structured psychotherapy, including behavioral activation and problem-solving therapy adapted for cognitive impairment, has been linked to fewer depressive episodes and better performance on neuropsychological tests that probe attention and working memory circuits.
Medication is no mere add‑on. When carefully prescribed, selective serotonin reuptake inhibitors can reduce depressive symptoms, improve sleep architecture, and indirectly support synaptic plasticity, the cellular process that underlies learning and recall in vulnerable hippocampal networks.
Family routines matter just as much. Regular daily schedules, caregiver education, and environmental cues reduce stress reactivity and dampen hypothalamic–pituitary–adrenal axis overdrive, a stress pathway associated with accelerated cortical atrophy in dementia.
What looks like soft care is, in practice, neuroprotection. Fold mental health into standard Alzheimer’s treatment, and you are not just easing sadness; you are defending what remains of the brain’s capacity to think, decide, and recognize a familiar face.
Loading...
